Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Lymphoma

  Free Subscription


20.11.2017

3 Blood
2 BMC Cancer
3 Br J Haematol
1 Curr Treat Options Oncol
1 Eur J Haematol
2 Hum Pathol
1 J Natl Cancer Inst
1 J Virol
2 Lancet Oncol
2 Leukemia
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Blood


  1. Diffuse large B-cell lymphoma in the elderly.
    Blood. 2017;130:2235.
    PubMed     Text format    

  2. CRANE GM, Perkins AS
    Leukemic presentation of diffuse large B-cell lymphoma: an unusual pattern associated with splenic involvement.
    Blood. 2017;130:2233.
    PubMed     Text format    

  3. AMENGUAL JE, Lichtenstein R, Lue J, Sawas A, et al
    A phase I study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma.
    Blood. 2017 Nov 15. pii: blood-2017-09-806737. doi: 10.1182/blood-2017-09-806737
    PubMed     Text format     Abstract available


    BMC Cancer

  4. ODUOR CI, Kaymaz Y, Chelimo K, Otieno JA, et al
    Integrative microRNA and mRNA deep-sequencing expression profiling in endemic Burkitt lymphoma.
    BMC Cancer. 2017;17:761.
    PubMed     Text format     Abstract available

  5. LIU Y, Wang X, Ding N, Mi L, et al
    TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP.
    BMC Cancer. 2017;17:743.
    PubMed     Text format     Abstract available


    Br J Haematol

  6. KARAKAWA A, Taoka K, Kaburaki T, Tanaka R, et al
    Clinical features and outcomes of secondary intraocular lymphoma.
    Br J Haematol. 2017 Nov 16. doi: 10.1111/bjh.15005.
    PubMed     Text format    

  7. LIN RJ, Ma H, Guo R, Troxel AB, et al
    Potentially inappropriate medication use in elderly non-Hodgkin lymphoma patients is associated with reduced survival and increased toxicities.
    Br J Haematol. 2017 Nov 16. doi: 10.1111/bjh.15027.
    PubMed     Text format     Abstract available

  8. FRAME IJ, Coberly J, Fuda FS, Chen M, et al
    Erythrophagocytosis by T-cell lymphoma cells in a patient with hereditary spherocytosis post-splenectomy.
    Br J Haematol. 2017 Nov 16. doi: 10.1111/bjh.15028.
    PubMed     Text format    


    Curr Treat Options Oncol

  9. NIU X, Chuang JC, Berry GJ, Wakelee HA, et al
    Anaplastic Lymphoma Kinase Testing: IHC vs. FISH vs. NGS.
    Curr Treat Options Oncol. 2017;18:71.
    PubMed     Text format     Abstract available


    Eur J Haematol

  10. SCHILLER J, Klein S, Engels M, Buttner R, et al
    A Cryptosporidium infection in a patient with relapsed T lymphoblastic lymphoma undergoing allogeneic stem cell transplantation.
    Eur J Haematol. 2017 Nov 15. doi: 10.1111/ejh.12998.
    PubMed     Text format     Abstract available


    Hum Pathol

  11. REE HJ, Ko YH, Yang SW
    Tumor-infiltrating T lymphocytes and morphogenesis of follicular lymphoma.
    Hum Pathol. 2017 Nov 9. pii: S0046-8177(17)30404.
    PubMed     Text format    

  12. XERRI L, Huet S, Salles G
    Tumor-infiltrating T lymphocytes and morphogenesis of follicular lymphoma-reply.
    Hum Pathol. 2017 Nov 7. pii: S0046-8177(17)30405.
    PubMed     Text format    


    J Natl Cancer Inst

  13. MORTON LM, Sampson JN, Armstrong GT, Chen TH, et al
    Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    J Virol

  14. COUSINS E, Gao Y, Sandford G, Nicholas J, et al
    Correction for Cousins et al., "Human Herpesvirus 8 Viral Interleukin-6 Signaling through gp130 Promotes Virus Replication in Primary Effusion Lymphoma and Endothelial Cells".
    J Virol. 2017;91.
    PubMed     Text format    


    Lancet Oncol

  15. EICHENAUER DA, Plutschow A, Kreissl S, Sokler M, et al
    Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
    Lancet Oncol. 2017 Nov 10. pii: S1470-2045(17)30696.
    PubMed     Text format     Abstract available

  16. FANALE MA
    Brentuximab vedotin for advanced Hodgkin's lymphoma.
    Lancet Oncol. 2017 Nov 10. pii: S1470-2045(17)30845.
    PubMed     Text format    


    Leukemia

  17. JIA YJ, Liu ZB, Wang WG, Sun CB, et al
    HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma.
    Leukemia. 2017 Sep 28. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  18. HARTMANN K, Illing A, Leithauser F, Baisantry A, et al
    Gene dosage reductions of Trf1 and/or Tin2 induce telomere DNA damage and lymphoma formation in aging mice.
    Leukemia. 2017 Nov 10. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available


    PLoS One

  19. KHARE D, Goldschmidt N, Bardugo A, Gur-Wahnon D, et al
    Plasma microRNA profiling: Exploring better biomarkers for lymphoma surveillance.
    PLoS One. 2017;12:e0187722.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: